We stimulate high-impact research. Our Trans-Omics for Precision Medicine (TOPMed) Program includes participants with high blood pressure, which may help us understand how genes contribute to differences in disease severity and how patients respond to treatment. The NHLBI Strategic Vision highlights ways we may support research over the next decade, including new efforts for studying high blood pressure.
Early signs of pulmonary arterial hypertension can be related to the trouble you have getting blood to your lungs to get oxygenated. You might experience shortness of breath and a fast heart beat while doing activities that are otherwise routine, such as climbing stairs. You might also have chest pain, a reduced appetite, and pain in your chest or upper right portion of your abdomen.
Genetics plays a role in hypertension, and much of essential hypertension could ultimately turn out to be genetic in origin. Genes are believed to have approximately 30 percent to 50 percent impact on blood pressure. Specific genes have not been identified as responsible for hypertension, however. This may be due to the fact that there are many genes that interact together to influence blood pressure, with some of these genetic variants being more common than others.

Dietary changes: The health care provider might recommend a diet that includes more vegetables (especially leafy green vegetables), fruits, low-fat dairy products, and fiber-rich foods, and fewer carbohydrates, fats, processed foods, and sugary drinks. He or she also might recommend preparing low-sodium dishes and not adding salt to foods. Watch out for foods with lots of hidden salt (like bread, sandwiches, pizza, and many restaurant and fast-food options).
Although the guidelines do not change the traditional definition of high blood pressure, they do call for more aggressive treatment of the condition through the use of a combination of blood-pressure lowering medications. In fact, they say that most people with high blood pressure will require two or more drugs to achieve a blood pressure goal of less than 140/90. The blood pressure goal in people with diabetes or kidney disease should be less than 130/80.
Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). This NHLBI study began in 1994 and lasted eight years. People with high blood pressure enrolled in one part of the study and people with high blood cholesterol enrolled in another part of the study. ALLHAT’s findings have informed how we treat high blood pressure and high blood cholesterol. Visit Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial for more information about all research activities and advances from this study.

3. Implement strategies to lower inflammation. Several cross-sectional and longitudinal studies connect high blood pressure with chronic inflammation, a driving force for nearly every disease on the planet. Lowering inflammation starts with what you put on your fork. Focus on anti-inflammatory foods like wild-caught seafood (rich in omega-3 fatty acids), freshly ground flax and chia seeds, spices like turmeric, and plenty of colorful plant foods. Good sleep, stress management, exercise, and the right nutrients can also help lower inflammation.
There is no treatment available for the causes of portal hypertension. However, treatment can prevent or manage the complications. Diet, medication (nonselective beta-blockers), endoscopic therapy, surgery, and radiology procedures can all help in treating or preventing symptoms of portal hypertension. If these treatments are unsuccessful in treating symptoms, transjugular intrahepatic portosystemic shunt (TIPS) or distal splenorenal shunt (DSRA) are two procedures that may reduce pressure in the portal veins. Maintaining a healthy lifestyle may help to prevent portal hypertension.